Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    0.00 (0.00%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Trading Update

18 Aug 2011 07:00

RNS Number : 5682M
B.P. Marsh & Partners PLC
18 August 2011
 



On behalf of: B. P. Marsh & Partners PLC ("B.P. Marsh", "the Company" or "the Group")

B.P. Marsh & Partners Plc

Trading Update

B.P. Marsh, a niche venture capital provider to early stage financial services businesses, is pleased to provide the market with an update on trading for the six month period to 31st July 2011. Since reporting our results on 1st June 2011 and against a backdrop of further global financial turmoil, the Group's portfolio companies continue to perform in line with management expectations.

On the 1st June 2011 the Group announced its annual results for the year ended 31st January 2011. At 31stJanuary 2011 the Group's Net Asset Value was £46.5m (equating to an NAV per share of 159p). As stated at the time of the annual results, the Board remains committed to narrowing the discount between the share price and NAV. At 31st July 2011 the Group had cash balances of £0.4m and outstanding loans of £1.25m (net cash at 31st January 2011 was £0.5m). As announced on 1st April 2011, £1.25m was drawn down from a Directors' Loan facility in order to complete the further investment in Besso Insurance Group Limited (formerly Besso Holdings Limited).

Hyperion Insurance Group Ltd ("Hyperion")

Howden Broking Group Ltd - PYV Ltd acquisition

Howden Broking Group (the broking subsidiary of Hyperion) reached agreement to acquire the broking activity of professional indemnity specialist PYV Ltd on 3rd May 2011. The acquisition has seen a significant team and book of business move over to Howden Broking Group. Hyperion's chief executive, David Howden, said, "In line with our group strategy we are actively looking at opportunities in the insurance market that will add value for our clients, the business and our shareholders. The acquisition of this book of business adds breadth and depth to our existing UK retail team".

Howden Insurance Brokers Ltd - Insurance Broker of the Year

Howden Insurance Brokers (the UK subsidiary of Howden Broking Group) won the Insurance Broker of the Year at the 2011 British Insurance Industry Awards on 6th July 2011.

The award recognises a company that can "demonstrate a real commitment to meeting customer needs and delivering a high quality of service across all the lines of its business", coupled with "evidence of a proven track record of profitability with a clear strategy to deliver future growth, either in existing or new markets".

Tim Coles, CEO of Howden Broking Group and Howden Insurance Brokers said, "It is a wonderful accolade and testament to the drive, ambition and spirit of every single person in the Howden Broking Group across the world - all of whom work unceasingly to deliver outstanding results for our clients".

US Risk UK Ltd ("US Risk UK")

Oxford Insurance Brokers Ltd

Oxford Insurance Brokers Ltd ("Oxford"), the 100% owned subsidiary of US Risk UK, has added to its existing production teams in its Speciality Lines Division, as well as its UK Professional Indemnity and International Divisions. These new personnel hires demonstrate Oxford's ambitions for development and Oxford continues to pursue other individuals and teams who are interested in joining a growing, motivated business.

Neill Cotton, managing director of Oxford commented, "We have been successful in attracting some experienced professionals during the first six months of 2011. This has assisted us in our growth and diversification plans and we are confident that we will be able to add to these new teams, in order to achieve our development targets, over the next 12 months".

LEBC Holdings Limited ("LEBC")

The Retirement Adviser, part of the Longevity Risk Division at LEBC Group Limited (the trading subsidiary of LEBC) which is headed by Nick Flynn, won the Best Annuity Planner award at the 2011 Money Marketing Awards.

New Business Opportunities

The Group focuses on minority investment opportunities in financial services business, typically taking an equity stake of between 15% and 45%. The geographic focus is predominantly within the UK but the Group is investigating opportunities to strengthen relationships with potential US-based investment partners, recognising that in the insurance market in particular there are increasing investment opportunities in the North American region. These are in part being generated by fall-out from continuing consolidation in the "big three" insurance brokers (AON, Willis and Marsh), leading to potential opportunities for new investment and for the Group's existing portfolio companies.

Exit Opportunities

The Board continues to consider exit opportunities for both portfolio investments and for the Group itself as and when they may arise.

For further information please contact:

B.P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh/Millie Kenyon Tel: 020 7233 3112

 

Nominated Adviser and Broker

Arbuthnot Securities Limited

Nick Tulloch / Rebecca Gordon Tel: 020 7012 2000

 

Notes to Editors:

About B.P. Marsh & Partners Plc

B.P. Marsh's current portfolio contains 10 companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Over the past 20 years, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least four years.

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 14 years' experience in the financial services industry. Jonathan advises investee companies through several non-executive board appointments and evaluates new investment opportunities.

Daniel Topping is a Member of the Chartered Institute of Securities and Investment (MCSI) and an Associate Member of the Institute of Chartered Secretaries and Administrators (ACIS). Dan currently holds four non-executive board appointments through which he advises investee companies and he also evaluates new investment opportunities.

Camilla Kenyon was appointed as Head of Investor Relations at B. P. Marsh in February 2009, having four years of prior experience with the Company. Since then she has also been appointed as Head of the New Business Department, with responsibility for coordinating new investment opportunities and Chairing the New Business Committee.Millie currently has two non-executive appointments.

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSDTTIDLIL
Date   Source Headline
12th Sep 20257:00 amRNSNew Investment: Supporting the Growth of XPT Group
29th Aug 20253:54 pmRNSNew Investment - Supporting the Growth of Pantheon
22nd Aug 20252:32 pmRNSDirector/PDMR Shareholding
14th Aug 20257:00 amRNSNew Investment- supporting the growth of XPT Group
11th Aug 202512:50 pmRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
7th Aug 202512:44 pmRNSHolding(s) in Company
7th Aug 20257:05 amRNSBuyback Results, Transaction in Own Shares and TVR
7th Aug 20257:00 amRNSResult of Secondary Placing
6th Aug 20254:51 pmRNSProposed Buyback
6th Aug 20254:40 pmRNSPROPOSED SECONDARY PLACING
4th Aug 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
31st Jul 20258:05 amRNSPurchase of Own Shares and Total Voting Rights
17th Jul 202512:31 pmRNSResult of AGM
16th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
15th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
14th Jul 20252:10 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
11th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
3rd Jul 20254:30 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
30th Jun 20257:00 amRNSPurchase of Own Shares
30th Jun 20257:00 amRNSFollow-on equity purchase in and loan to Pantheon
24th Jun 20251:15 pmRNSNotice of AGM - correction
24th Jun 202511:39 amRNSNotice of AGM
20th Jun 202510:13 amRNSPurchase of Own Shares and Total Voting Rights
17th Jun 20257:00 amRNSNew Investment – Cameron Specialty HoldCo Limited
12th Jun 202512:30 pmRNSDirector/PDMR Shareholding
11th Jun 20254:18 pmRNSDirector/PDMR Shareholding
11th Jun 20253:33 pmRNSHolding(s) in Company
10th Jun 20254:45 pmRNSDirector/PDMR Shareholding
10th Jun 202511:30 amRNSFinal Dividend Declaration
10th Jun 20257:00 amRNSFinal Results for the Year to 31 January 2025
5th Jun 202511:15 amRNSSale of Interest in Sterling Insurance Pty Ltd
4th Jun 20252:45 pmRNSNew Investment - Amiga Speciality Holdings Limited
4th Jun 202512:23 pmRNSNotice of Annual Results and Investor Presentation
3rd Jun 202511:44 amRNSResult of Meeting
14th May 20255:34 pmRNSHolding(s) in Company
14th May 20254:53 pmRNSHolding(s) in Company
12th May 20253:17 pmRNSSecondary Share Sale
12th May 202512:15 pmRNSShare BuyBack, Notice of GM and Rule 9 Waiver
9th May 202512:49 pmRNSResult of Secondary Placing
8th May 20254:40 pmRNSProposed Secondary Placing
24th Apr 20259:59 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNew Investment - iO Partners
17th Apr 20251:45 pmRNSNew Share Buyback Programme
16th Apr 20254:45 pmRNSSpecial Dividend Declaration
7th Apr 20252:55 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.